Quick Links : Search PubMed , Finding Full Text , PubMed Advanced Search , Clinical Queries , Single Citation Matcher , FAQs & User Guide , Explore MeSH Database , Explore PubMed Journals
dbGap News
News and announcements from the database of Genotypes and Phenotypes (dbGaP)
- New | phs003111.v2.p2 | Childhood Cancer Data Initiative (CCDI): Clonal Evolution During Metastatic Spread in High-Risk Neuroblastoma July 31, 2026Childhood Cancer Data Initiative (CCDI): Clonal Evolution During Metastatic Spread in High-Risk Neuroblastoma (study page | release notes)
- New | phs001703.v6.p1 | Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression July 31, 2026Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression (study page | release notes)
- New | phs004608.v1.p1 | Elucidation of Genotype-Phenotype Relationships Using Human Stem Cell Models July 30, 2026Elucidation of Genotype-Phenotype Relationships Using Human Stem Cell Models (study page | release notes)
- New | phs003067.v3.p3 | Using NGS to Sequence Whole Genomes to Identify Genes Underlying ALS July 30, 2026Using NGS to Sequence Whole Genomes to Identify Genes Underlying ALS (study page | release notes)
- New | phs004175.v1.p1 | Dissecting the Role of the Microenvironment in Follicular Lymphoma Transformation July 30, 2026Dissecting the Role of the Microenvironment in Follicular Lymphoma Transformation (study page | release notes)
- New | phs004039.v1.p1 | NCTN: Dexamethasone Compared with Prednisone During Induction Therapy and Methotrexate with or without Leucovorin During Maintenance Therapy in Treating Patients with Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (AALL0232) July 29, 2026NCTN: Dexamethasone Compared with Prednisone During Induction Therapy and Methotrexate with or without Leucovorin During Maintenance Therapy in Treating Patients with Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (AALL0232) (study page | release notes)
- New | phs004142.v1.p1 | NCTN: A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD (AAML1031) July 29, 2026NCTN: A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD (AAML1031) (study page | release notes)
- New | phs001138.v5.p3 | National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Gabriella Miller Kids First Pediatric Research Program of the Pediatric Cardiac Genetics Consortium (PCGC) July 28, 2026National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Gabriella Miller Kids First Pediatric Research Program of the Pediatric Cardiac Genetics Consortium (PCGC) (study page | release notes)
- New | phs004139.v1.p1 | NCTN: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor (AREN0532) July 28, 2026NCTN: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor (AREN0532) (study page | release notes)
- New | phs004133.v1.p1 | NCTN: Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma (ANBL0532) July 27, 2026NCTN: Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma (ANBL0532) (study page | release notes)